Intchains Group
ICG
BIGG DIGITAL ASSETS INC
BBKCF
NEPTUNE DIGITAL ASSETS CORP
NPPTF
Bitdeer Technologies
BTDR
MicroStrategy
MSTR
US Stock MarketDetailed Quotes
RARE Ultragenyx Pharmaceutical
- 44.220
- +0.750+1.73%
Close Dec 20 16:00 ET
- 44.220
- 0.0000.00%
Post 20:01 ET
4.08BMarket Cap-6.96P/E (TTM)
44.450High42.850Low1.73MVolume43.480Open43.470Pre Close76.45MTurnover1.95%Turnover RatioLossP/E (Static)92.34MShares60.37052wk High11.77P/B3.94BFloat Cap37.02052wk Low--Dividend TTM89.11MShs Float179.647Historical High--Div YieldTTM3.68%Amplitude31.520Historical Low44.099Avg Price1Lot Size
Ultragenyx Pharmaceutical News
Ultragenyx Pharmaceutical | 8-K: Current report
Ultragenyx Pharmaceutical | 8-K: Current report
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Huizenga Theodore Alan
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer KAKKIS EMIL D
Ultragenyx Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144
Ultragenyx Pharmaceutical | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RTW Investments, LP(2.1%),Roderick Wong, M.D.(2.1%)
Ultragenyx Pharmaceutical | 8-K: Current report
Ultragenyx Pharmaceutical | 10-Q: Q3 2024 Earnings Report
Ultragenyx Pharmaceutical | 8-K: Ultragenyx Reports Third Quarter 2024 Financial Results and Corporate Update
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Horn Howard
Ultragenyx Pharmaceutical | 8-K: Current report
Ultragenyx Pharmaceutical | 8-K: Current report
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Huizenga Theodore Alan
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer KAKKIS EMIL D
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Huizenga Theodore Alan
Ultragenyx Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer KAKKIS EMIL D
Ultragenyx Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144
Ultragenyx Pharmaceutical | 10-Q: Q2 2024 Earnings Report
Ultragenyx Pharmaceutical | 8-K: Ultragenyx Reports Second Quarter 2024 Financial Results and Corporate Update
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.